These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20106872)

  • 1. Constitutive beta-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development.
    Berthon A; Sahut-Barnola I; Lambert-Langlais S; de Joussineau C; Damon-Soubeyrand C; Louiset E; Taketo MM; Tissier F; Bertherat J; Lefrançois-Martinez AM; Martinez A; Val P
    Hum Mol Genet; 2010 Apr; 19(8):1561-76. PubMed ID: 20106872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex.
    Kim AC; Reuter AL; Zubair M; Else T; Serecky K; Bingham NC; Lavery GG; Parker KL; Hammer GD
    Development; 2008 Aug; 135(15):2593-602. PubMed ID: 18599507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the role of Igf2 in adrenal tumour development in transgenic mouse models.
    Drelon C; Berthon A; Ragazzon B; Tissier F; Bandiera R; Sahut-Barnola I; de Joussineau C; Batisse-Lignier M; Lefrançois-Martinez AM; Bertherat J; Martinez A; Val P
    PLoS One; 2012; 7(8):e44171. PubMed ID: 22952916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
    Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
    Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precursor lesions of the adrenal gland.
    van Nederveen FH; de Krijger RR
    Pathobiology; 2007; 74(5):285-90. PubMed ID: 17890895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
    Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
    Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precancerous lesions upon sporadic activation of beta-catenin in mice.
    Coste I; Freund JN; Spaderna S; Brabletz T; Renno T
    Gastroenterology; 2007 Apr; 132(4):1299-308. PubMed ID: 17408631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin.
    Cadoret A; Ovejero C; Saadi-Kheddouci S; Souil E; Fabre M; Romagnolo B; Kahn A; Perret C
    Cancer Res; 2001 Apr; 61(8):3245-9. PubMed ID: 11309273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic role of the frizzled-7/beta-catenin pathway in hepatocellular carcinoma.
    Merle P; Kim M; Herrmann M; Gupte A; Lefrançois L; Califano S; Trépo C; Tanaka S; Vitvitski L; de la Monte S; Wands JR
    J Hepatol; 2005 Nov; 43(5):854-62. PubMed ID: 16098625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
    Calvisi DF; Factor VM; Loi R; Thorgeirsson SS
    Cancer Res; 2001 Mar; 61(5):2085-91. PubMed ID: 11280770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-catenin in adrenal zonation and disease.
    Little DW; Dumontet T; LaPensee CR; Hammer GD
    Mol Cell Endocrinol; 2021 Feb; 522():111120. PubMed ID: 33338548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammary gland tissue targeted overexpression of human protease-activated receptor 1 reveals a novel link to beta-catenin stabilization.
    Yin YJ; Katz V; Salah Z; Maoz M; Cohen I; Uziely B; Turm H; Grisaru-Granovsky S; Suzuki H; Bar-Shavit R
    Cancer Res; 2006 May; 66(10):5224-33. PubMed ID: 16707447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression.
    Fischer AN; Fuchs E; Mikula M; Huber H; Beug H; Mikulits W
    Oncogene; 2007 May; 26(23):3395-405. PubMed ID: 17130832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal hyperplasia and tumours in mice in connection with aberrant pituitary-gonadal function.
    Bernichtein S; Peltoketo H; Huhtaniemi I
    Mol Cell Endocrinol; 2009 Mar; 300(1-2):164-8. PubMed ID: 19007852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of gastric tumors in Apc(Min/+) mice by the activation of the beta-catenin/Tcf signaling pathway.
    Tomita H; Yamada Y; Oyama T; Hata K; Hirose Y; Hara A; Kunisada T; Sugiyama Y; Adachi Y; Linhart H; Mori H
    Cancer Res; 2007 May; 67(9):4079-87. PubMed ID: 17483318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of beta-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation.
    Bierie B; Nozawa M; Renou JP; Shillingford JM; Morgan F; Oka T; Taketo MM; Cardiff RD; Miyoshi K; Wagner KU; Robinson GW; Hennighausen L
    Oncogene; 2003 Jun; 22(25):3875-87. PubMed ID: 12813461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P53 levels determine outcome during beta-catenin tumor initiation and metastasis in the mammary gland and male germ cells.
    Ridgeway AG; McMenamin J; Leder P
    Oncogene; 2006 Jun; 25(25):3518-27. PubMed ID: 16434961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between HSP60 and beta-catenin promotes metastasis.
    Tsai YP; Yang MH; Huang CH; Chang SY; Chen PM; Liu CJ; Teng SC; Wu KJ
    Carcinogenesis; 2009 Jun; 30(6):1049-57. PubMed ID: 19369584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant progression of invasive tumour cells seen in hypoxia present an accumulation of beta-catenin in the nucleus at the tumour front.
    Demir R; Dimmler A; Naschberger E; Demir I; Papadopoulos T; Melling N; Sturzl M; Hohenberger W
    Exp Mol Pathol; 2009 Oct; 87(2):109-16. PubMed ID: 19481539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.